- Report
- November 2024
- 150 Pages
United Kingdom
From €1276EUR$1,394USD£1,084GBP
€1823EUR$1,991USD£1,549GBP
- Report
- November 2024
- 150 Pages
Europe
From €1446EUR$1,580USD£1,229GBP
€2066EUR$2,257USD£1,756GBP
- Report
- July 2024
- 280 Pages
Global
From €1701EUR$1,859USD£1,446GBP
€2430EUR$2,655USD£2,066GBP
- Report
- August 2021
- 217 Pages
Global
From €2379EUR$2,598USD£2,022GBP
€3398EUR$3,712USD£2,888GBP
- Book
- February 2015
- 400 Pages
- Book
- January 2015
- 464 Pages
- Book
- October 2012
- 1570 Pages
The Vaccine Manufacturing market is a subset of the biopharmaceutical industry, which focuses on the development and production of vaccines. Vaccines are biological products that are used to prevent and treat infectious diseases. Vaccine manufacturing involves the production of active ingredients, such as antigens, as well as the formulation and packaging of the final product. Vaccine manufacturers must adhere to strict regulatory standards to ensure the safety and efficacy of their products.
The Vaccine Manufacturing market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more